Nutu™ Digital Health Platform for Obesity

DS
Overseen ByDrew Sayer, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Alabama at Birmingham
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests a new digital health tool called Nutu™ to determine its effectiveness in assisting people with obesity when added to their regular care program. The study compares two groups: one receives standard care, including nutrition counseling and doctor visits, while the other receives the same care plus access to the Nutu™ platform. The goal is to assess whether the Nutu™ platform enhances the effectiveness and acceptability of obesity treatment. Participants already in the FLOW clinical program for obesity may be well-suited for this trial. As an unphased trial, this study provides a unique opportunity to explore innovative solutions for obesity management.

Do I need to stop my current medications for the trial?

The trial information does not specify whether you need to stop taking your current medications.

What prior data suggests that the Nutu™ digital health platform is safe for use in obesity treatment?

In a previous study, researchers examined the acceptance of the Nutu™ digital health platform as part of a weight loss program. The study reported no serious safety issues and focused on user engagement, finding it a helpful tool for managing obesity.

As a digital health platform, Nutu™ does not involve medication or medical procedures, making it generally low-risk compared to drug or surgical treatments. However, like many digital tools, concerns about data privacy and long-term user engagement may arise.

Overall, evidence suggests that Nutu™ is a safe option for weight management, with no major negative effects reported in the available studies.12345

Why are researchers excited about this trial?

Researchers are excited about the Nutu™ digital health platform for obesity because it offers a unique, tech-driven approach to weight management. Unlike traditional options such as diet plans, exercise, and medication, Nutu™ integrates digital tools to support lifestyle changes. This platform provides personalized guidance and real-time tracking, making it easier and more engaging for users to stick to their health goals. By combining standard care with innovative technology, Nutu™ has the potential to enhance long-term success in managing obesity.

What evidence suggests that the Nutu™ digital health platform is effective for obesity?

Research shows that digital health tools like Nutu™ can help people manage their weight by encouraging healthy habits. One study found that weight loss apps, which often include coaching and feedback, work better when combined with other treatments. In this trial, participants in the FLOW + Nutu™ Offer arm will receive standard FLOW care and can access the Nutu™ digital health platform. In a 6-month study, people using a digital health app for obesity lost a significant amount of weight. These tools help users track their progress and stay motivated. Nutu™ aims to offer similar benefits as part of primary care programs for managing obesity.12367

Who Is on the Research Team?

DS

Drew Sayer, PhD

Principal Investigator

University of Alabama at Birmingham

Are You a Good Fit for This Trial?

This trial is for patients already enrolled in the FLOW clinical program at UAB, focusing on those who need help managing childhood or adult obesity and related cardiovascular risks.

Inclusion Criteria

All patients enrolled in the FLOW clinical program are eligible.

Exclusion Criteria

Not a patient of the FLOW clinical program at UAB.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive the standard 12-month FLOW program, with or without the Nutu™ digital health platform

12 months
Quarterly visits

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Nutu™

Trial Overview

The study tests how well adding the Nutu™ digital health platform to regular obesity treatment works. It's a Zelen randomized controlled trial, meaning some people will get this new tool while others won't, by chance.

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Active Control

Group I: FLOW + Nutu™ OfferExperimental Treatment2 Interventions
Group II: Standard FLOW ProgramActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Alabama at Birmingham

Lead Sponsor

Trials
1,677
Recruited
2,458,000+

Willow Laboratories, Inc.

Collaborator

Citations

Retrospective Cohort Study of a Digital Weight Loss Service

Digital platforms offering coaching, self-monitoring, and automated feedback have the potential to further augment pharmacological efficacy.

Augmenting Primary Care-Based Obesity Management ...

This study evaluates the acceptability and clinical effectiveness of integrating the Nutu™ digital health platform into a comprehensive primary ...

Augmenting Primary Care-Based Obesity Management With ...

This study evaluates the acceptability and clinical effectiveness of integrating the Nutu™ digital health platform into a comprehensive ...

6-months results from a randomized controlled trial

Efficacy of a digital health application for weight management in people with obesity: 6-months results from a randomized controlled trial.

Can Digital Technologies Be Useful for Weight Loss in ...

This review aimed to assess the effectiveness of digital resources in supporting behavior changes, and thus influencing weight loss, in people with overweight ...

Integrating digital health into pediatric obesity management

Despite these advancements, DHIs still face major challenges, including unequal access, data privacy concerns, and a lack of long-term outcome evaluations.

Semaglutide Safety Update: Rare Optic Nerve Risks Clarified

Their digital health platform, Nutu, delivers personalized, CDC-aligned diabetes prevention programming with AI-powered coaching, expanding ...